http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100524082-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3683 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3625 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 |
| filingDate | 2003-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100524082-B1 |
| titleOfInvention | Calcification-resistant Bioprosthetic Tissue Implants Coupled Arginine and Method the Same |
| abstract | In the present invention, by arranging arginine (L-arginine), one of the bioprosthetic tissue amino acids, the present invention discloses a biotissue implant that significantly reduces blood coagulation, wound healing and immune function, and calcification. have.n n n The biotissue graft of the present invention has an anti-calcification function, which improves anti-calcification function and in vivo durability, improves blood compatibility and promotes angiogenesis, thereby improving artificial heart valves and circulatory surgery patches (Patch) ), Can be used as a living tissue implant material for tissue blood vessels and skin regeneration. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101075399-B1 |
| priorityDate | 2003-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.